Transcriptomics

Dataset Information

0

Reprogramming Bacterial Energetics Reverse Lactate-Mediated Immunosuppression for Synergistic Cancer Immunotherapy


ABSTRACT: The immunosuppressive tumor microenvironment (TME), driven by lactate accumulation, critically limits cancer immunotherapy efficacy. Here, we engineered Shewanella oneidensis MR-1 (S. oneidensis) by reprogramming energy metabolism to reverse lactate-driven immunosuppression in the TME. Integration of polyphosphate kinase 2 (PPK2-Ⅰ) and NAD kinase (NADK) markedly augmented bacterial bioenergetics, boosting ATP production by 287.5% and elevating the NADH/NAD⁺ ratio by 299.9% compared to the wild-type strain. This bioenergetic enhancement accelerated targeted lactate depletion and increased intratumoral bacterial persistence, while impairing tumor lactate transport via downregulation of monocarboxylate transporters MCT1 and MCT4. Crucially, metabolic remodeling reversed immunosuppression by enhancing antigen presentation and CD8+ T cell infiltration, and reducing regulatory T cells (Tregs), thereby converting immunologically “cold” tumors into immunoreactive phenotypes. When combined with αPD-1 immunotherapy, this strategy synergistically amplified antitumor efficacy and established durable immunological memory against recurrence. Collectively, our work establishes a paradigm for bacterial bioenergetic engineering to advance cancer immunotherapy.

ORGANISM(S): Shewanella oneidensis MR-1

PROVIDER: GSE330449 | GEO | 2026/05/13

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2013-03-21 | E-GEOD-45313 | biostudies-arrayexpress
2024-05-10 | GSE230896 | GEO
2025-10-17 | PXD058542 | Pride
2012-07-19 | GSE39474 | GEO
2023-12-29 | GSE199828 | GEO
2023-12-29 | GSE199830 | GEO
2023-12-29 | GSE199829 | GEO
2013-03-21 | GSE45313 | GEO
2012-05-01 | GSE25821 | GEO
2010-12-01 | E-GEOD-20343 | biostudies-arrayexpress